This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Charles River Laboratories International Inc. advanced 4.6% to $170.51 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.1% to 43,461.21 and the S&P 500 Index falling 0.5% to 5,983.25.
This was the stock's second consecutive day of gains.
Charles River Laboratories International Inc. closed 38.0% short of its 52-week high of $275.00, which the company reached on March 8th.
The stock outperformed some of its competitors, as Labcorp Holdings Inc. rose 0.6% to $251.43, Alnylam Pharmaceuticals Inc. fell 0.7% to $248.94, and Bio-Techne Corp. rose 0.99% to $65.56.
Trading volume totaled 1.4 million, compared to the 50-day average of 896,395.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 24, 2025 16:35 ET (21:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.